192 related articles for article (PubMed ID: 27581750)
1. Sharing success - understanding barriers and enablers to secondary prophylaxis delivery for rheumatic fever and rheumatic heart disease.
Chamberlain-Salaun J; Mills J; Kevat PM; Rémond MG; Maguire GP
BMC Cardiovasc Disord; 2016 Aug; 16(1):166. PubMed ID: 27581750
[TBL] [Abstract][Full Text] [Related]
2. Improvement in rheumatic fever and rheumatic heart disease management and prevention using a health centre-based continuous quality improvement approach.
Ralph AP; Fittock M; Schultz R; Thompson D; Dowden M; Clemens T; Parnaby MG; Clark M; McDonald MI; Edwards KN; Carapetis JR; Bailie RS
BMC Health Serv Res; 2013 Dec; 13():525. PubMed ID: 24350582
[TBL] [Abstract][Full Text] [Related]
3. A qualitative examination of secondary prophylaxis in rheumatic heart disease: factors influencing adherence to secondary prophylaxis in Uganda.
Huck DM; Nalubwama H; Longenecker CT; Frank SH; Okello E; Webel AR
Glob Heart; 2015 Mar; 10(1):63-69.e1. PubMed ID: 25754568
[TBL] [Abstract][Full Text] [Related]
4. Improving Delivery of Secondary Prophylaxis for Rheumatic Heart Disease in a High-Burden Setting: Outcome of a Stepped-Wedge, Community, Randomized Trial.
Ralph AP; de Dassel JL; Kirby A; Read C; Mitchell AG; Maguire GP; Currie BJ; Bailie RS; Johnston V; Carapetis JR
J Am Heart Assoc; 2018 Jul; 7(14):. PubMed ID: 30018165
[TBL] [Abstract][Full Text] [Related]
5. Prophylactic penicillin by the full moon: a novel approach in Central Australia that may help to reduce the risk of rheumatic heart disease.
Kearns TM; Schultz R; McDonald V; Andrews RM
Rural Remote Health; 2010; 10(3):1464. PubMed ID: 20795756
[TBL] [Abstract][Full Text] [Related]
6. Adherence rates and risk factors for suboptimal adherence to secondary prophylaxis for rheumatic fever.
Kevat PM; Gunnarsson R; Reeves BM; Ruben AR
J Paediatr Child Health; 2021 Mar; 57(3):419-424. PubMed ID: 33340191
[TBL] [Abstract][Full Text] [Related]
7. Approaches to Improving Adherence to Secondary Prophylaxis for Rheumatic Fever and Rheumatic Heart Disease: A Literature Review with a Global Perspective.
Rémond MG; Coyle ME; Mills JE; Maguire GP
Cardiol Rev; 2016; 24(2):94-8. PubMed ID: 25807106
[TBL] [Abstract][Full Text] [Related]
8. Preliminary consultation on preferred product characteristics of benzathine penicillin G for secondary prophylaxis of rheumatic fever.
Wyber R; Boyd BJ; Colquhoun S; Currie BJ; Engel M; Kado J; Karthikeyan G; Sullivan M; Saxena A; Sheel M; Steer A; Mucumbitsi J; Zühlke L; Carapetis J
Drug Deliv Transl Res; 2016 Oct; 6(5):572-8. PubMed ID: 27465618
[TBL] [Abstract][Full Text] [Related]
9. Priorities for improved management of acute rheumatic fever and rheumatic heart disease: analysis of cross-sectional continuous quality improvement data in Aboriginal primary healthcare centres in Australia.
Katzenellenbogen JM; Bond-Smith D; Ralph AP; Wilmot M; Marsh J; Bailie R; Matthews V
Aust Health Rev; 2020 Apr; 44(2):212-221. PubMed ID: 32241338
[TBL] [Abstract][Full Text] [Related]
10. RHD elimination: action needed beyond secondary prophylaxis.
Hardie K; Ralph AP; de Dassel JL
Aust N Z J Public Health; 2020 Oct; 44(5):427. PubMed ID: 32510810
[No Abstract] [Full Text] [Related]
11. Secondary prophylaxis for rheumatic fever: simple concepts, difficult delivery.
Wilson N
World J Pediatr Congenit Heart Surg; 2013 Oct; 4(4):380-4. PubMed ID: 24327631
[TBL] [Abstract][Full Text] [Related]
12. Secondary Prevention of Rheumatic Heart Disease in Nepal: Are We Going Backward?
Regmi PR; Dhungel M; Kafle R
JNMA J Nepal Med Assoc; 2022 Sep; 60(253):832-835. PubMed ID: 36705119
[TBL] [Abstract][Full Text] [Related]
13. Rheumatic heart disease: progress and challenges in India.
Shah B; Sharma M; Kumar R; Brahmadathan KN; Abraham VJ; Tandon R
Indian J Pediatr; 2013 Mar; 80 Suppl 1():S77-86. PubMed ID: 22941214
[TBL] [Abstract][Full Text] [Related]
14. Clinic factors associated with better delivery of secondary prophylaxis in acute rheumatic fever management.
Quinn E; Girgis S; Van Buskirk J; Matthews V; Ward JE
Aust J Gen Pract; 2019 Dec; 48(12):859-865. PubMed ID: 31774991
[TBL] [Abstract][Full Text] [Related]
15. Effect of secondary penicillin prophylaxis on valvular changes in patients with rheumatic heart disease in Far North Queensland.
Haran S; Crane N; Kazi S; Axford-Haines L; White A
Aust J Rural Health; 2018 Apr; 26(2):119-125. PubMed ID: 29168587
[TBL] [Abstract][Full Text] [Related]
16. Compliance of secondary prophylaxis for controlling rheumatic fever and rheumatic heart disease in a rural area of northern India.
Kumar R; Thakur JS; Aggarwal A; Ganguly NK
Indian Heart J; 1997; 49(3):282-8. PubMed ID: 9291651
[TBL] [Abstract][Full Text] [Related]
17. Penicillin Dried Blood Spot Assay for Use in Patients Receiving Intramuscular Benzathine Penicillin G and Other Penicillin Preparations To Prevent Rheumatic Fever.
Page-Sharp M; Coward J; Moore BR; Salman S; Marshall L; Davis TME; Batty KT; Manning L
Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28559267
[TBL] [Abstract][Full Text] [Related]
18. A population pharmacokinetic study of benzathine benzylpenicillin G administration in children and adolescents with rheumatic heart disease: new insights for improved secondary prophylaxis strategies.
Hand RM; Salman S; Newall N; Vine J; Page-Sharp M; Bowen AC; Gray K; Baker A; Kado J; Joseph J; Marsh J; Ramsay J; Sika-Paotonu D; Batty KT; Manning L; Carapetis J
J Antimicrob Chemother; 2019 Jul; 74(7):1984-1991. PubMed ID: 30989171
[TBL] [Abstract][Full Text] [Related]
19. Seven key actions to eradicate rheumatic heart disease in Africa: the Addis Ababa communiqué.
Watkins D; Zuhlke L; Engel M; Daniels R; Francis V; Shaboodien G; Kango M; Abul-Fadl A; Adeoye A; Ali S; Al-Kebsi M; Bode-Thomas F; Bukhman G; Damasceno A; Goshu DY; Elghamrawy A; Gitura B; Haileamlak A; Hailu A; Hugo-Hamman C; Justus S; Karthikeyan G; Kennedy N; Lwabi P; Mamo Y; Mntla P; Sutton C; Mocumbi AO; Mondo C; Mtaja A; Musuku J; Mucumbitsi J; Murango L; Nel G; Ogendo S; Ogola E; Ojji D; Olunuga TO; Redi MM; Rusingiza KE; Sani M; Sheta S; Shongwe S; van Dam J; Gamra H; Carapetis J; Lennon D; Mayosi BM
Cardiovasc J Afr; 2016 May/Jun 23; 27(3):184-187. PubMed ID: 26815006
[TBL] [Abstract][Full Text] [Related]
20. A programme to increase appropriate usage of benzathine penicillin for management of streptococcal pharyngitis and rheumatic heart disease in Zambia.
Long A; Lungu JC; Machila E; Schwaninger S; Spector J; Tadmor B; Fishman M; Mayosi BM; Musuku J
Cardiovasc J Afr; 2017; 28(4):242-247. PubMed ID: 28906539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
